Nearly nine months of joint replacement surgery has been lost - around 160,000 fewer operations – since the start of the COVID-19 pandemic, a new study led by the University of Bristol has found. The research suggests returning to pre-pandemic levels will not tackle the backlog, and even with rapid expansion, it will take many years, if not decades, to fix this joint replacement crisis.
People who experience an arterial ischemic stroke (AIS) or transient ischemic stroke (TIA) are at an increased risk of suffering a second stroke or other major adverse cardiovascular event (MACE), making it critically important to identify risk factors and treatments to prevent these subsequent occurrences. The new study, led by Boston University School of Public Health (BUSPH) and University of Bristol researchers, has identified new genetic and molecular risk factors that may reveal new pathways for treating patients after they experience their first stroke.
Researchers at the University of Bristol are joining forces with Bristol City Council and other partners in a bid to help reduce knife crime locally and beyond.
Children exposed to the anti-seizure drug lamotrigine during pregnancy were at no increased risk for autism or intellectual disability than those exposed to other anti-seizure medications, according to a new study on the use of eight different anti-seizure drugs published in Nature Communications today [15 November].
Two new studies to understand more about type 1 diabetes and how it develops in people who already have early markers of the disease in their blood are announced today [14 November] on World Diabetes Day. The awards, totalling over £1 million will help University of Bristol researchers find out how the disease, which affects up to 400,000 people in the UK, could be prevented in future.
A national study involving Bristol’s Children of the 90s has found the "booster" vaccine led to a substantial increase in the antibodies that help protect against coronavirus. High levels of antibodies is associated with lower risk of severe infection.
A new study that examined health data on 18 million people reveals higher incidence of mental illnesses for up to a year following severe COVID-19 in unvaccinated people. Vaccination appeared to mitigate the adverse effects of COVID-19 on mental illnesses. The University of Bristol-led study, published in JAMA Psychiatry today [21 August], investigated associations of COVID-19 with mental illnesses according to time since diagnosis and vaccination status.
Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind today. The latest findings from the ProtecT trial, led by the Universities of Bristol and Oxford, are presented today [12 March] at the European Association of Urology (EAU) Congress in Milan and published in the New England Journal of Medicine.
An anti-aging gene discovered in a population of centenarians has been shown to rewind the heart's biological age by 10 years. The breakthrough, published in Cardiovascular Research and led by scientists at the University of Bristol and the MultiMedica Group in Italy, offers a potential target for patients with heart failure.
Patients could benefit from a programme of 16 rapid research projects announced today [22 January] that will examine how to ease winter pressures faced by the NHS – compounded this year by COVID-19 and a record flu season, and the cost-of-living crisis.
